
|Videos|February 1, 2023
Advice for Community Oncologists who Treat Patients with NSCLC
Author(s)Mark Socinski, MD, Joshua K. Sabari, MD
Mark Socinski, MD and Joshua Sabari, MD, share their insight for community oncologists who treat patients with KRASG12C-mutated NSCLC with CNS metastases.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
Long-Term Outcomes Offer Reassurance on Quadruplet Use in Transplant-Ineligible NDMM
4
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
5



































